Gardiner, Donald L <br/><br/>
Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.  [electronic resource] 

 -  Expert review of anti-infective therapy  Nov 2009 
 - 1087-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1744-8336 
<br/><br/><label>Standard No.: </label>10.1586/eri.09.93  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminopeptidases--antagonists & inhibitors<br/>Animals<br/>Antimalarials--chemistry<br/>Aspartic Acid Endopeptidases--antagonists & inhibitors<br/>Drug Design<br/>Enzyme Inhibitors--chemistry<br/>Humans<br/>Hypoxanthine Phosphoribosyltransferase--antagonists & inhibitors<br/>Malaria, Falciparum--drug therapy<br/>Pentosyltransferases--antagonists & inhibitors<br/>Plasmodium falciparum--drug effects<br/>Protozoan Proteins--antagonists & inhibitors